Inflammatory dysregulation of blood monocytes in Parkinson's disease patients. - Wikidata - awgldk - TriplyDB

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

http://www.wikidata.org/entity/Q34363511

about

Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases Epigenetic DNA Methylation Profiling with MSRE: A Quantitative NGS Approach Using a Parkinson's Disease Test Case LRRK2 levels in immune cells are increased in Parkinson's disease Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation.Immune aging, dysmetabolism, and inflammation in neurological diseases.Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem Cells Monocyte Subsets and Related Chemokines in Carotid Artery Stenosis and Ischemic Stroke.Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease.European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection.Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes.The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal.Salsolinol Damaged Neuroblastoma SH-SY5Y Cells Induce Proliferation of Human Monocyte THP-1 Cells Through the mTOR Pathway in a Co-culture System.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.LRRK2 contributes to monocyte dysregulation in Parkinson's disease.Modeling neuro-immune interactions during Zika virus infection.Parkinson's disease: experimental models and reality.Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease.TLR4 and TLR2 activation is differentially associated with age during Parkinson's disease.Differential contribution of microglia and monocytes in neurodegenerative diseases.Impaired activation of ALS monocytes by exosomes.Abnormalities of age-related T cell senescence in Parkinson's disease.A monocyte gene expression signature in the early clinical course of Parkinson's disease Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease Interaction of systemic oxidative stress and mesial temporal network degeneration in Parkinson's disease with and without cognitive impairment Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention Functional alterations of myeloid cells during the course of Alzheimer's disease

P2860

Q26770676-0F2D2F90-F6C1-4903-B268-69497130B2AF Q28393074-2EABCE2B-7056-4AE3-8130-3F3D0A425F0F Q33765746-A0BC4291-4009-44C6-AEE4-06735D5C0C38 Q35289164-35C3EC5E-162D-4324-9196-691A14F04615 Q35484552-745E5053-DEF1-4511-BCD7-0A543DC5E2B9 Q35677347-E1F58892-4543-48A0-842B-10DBBD8B3484 Q36182364-8E7F0F11-31B6-43B5-8DE1-1E65D2E5AB49 Q36846847-B1414929-3D8B-4ECD-896E-C1EB5B17C43D Q37516494-3AEA509D-CF97-4267-BEB9-A925CD4B4BB1 Q37696024-F860D2FB-9E1F-42E4-87A7-4C1CB9550957 Q37701959-D756CE8C-DB73-4C02-8F45-19735E112A9E Q37713310-097C5DE3-D4FB-46A0-BB99-F32435827E3C Q38670012-33AF3024-DF25-4A0B-83DB-00B9830C0B40 Q38674162-385F9A3D-D5D8-477F-B5BA-89B3F9B22DE6 Q38869831-7990CADB-7935-43E7-9C36-7FCD8FDA848B Q38899693-553C3925-8B6C-40C4-B039-6D365DDFDE4C Q39010887-56E80231-158C-46F5-860B-C392CFE73097 Q39901740-785C090D-1DC0-4E89-9EAF-2415F1ACB8AF Q40768273-760DF6DB-6106-4284-9BCD-5DE9B5F7A3AC Q40960833-399FA29C-8A5B-4933-A62F-497450543942 Q42363462-CAF83791-C2E6-4110-8986-553ED0FB7296 Q43047307-5AAAA633-4431-4A7C-8665-7A41DA5F7A41 Q47389506-56EB90AC-A001-4292-AE81-664835319F9B Q47564469-2A0DE5B6-96D1-4CAF-AF46-D24EB8B9E18A Q47575506-AE34CCAE-0049-41AE-AD73-5D6618D6DE17 Q47704026-A2D49184-A6BC-4777-BCB7-1607A06D5576 Q48141250-97DFEF79-0DCA-4AB7-A512-627A31684B5F Q51519602-86D58918-5115-4B03-A85D-49DA98C52556 Q55078392-BA843983-9A4C-4DA2-8C2D-FE5CE89176D8 Q57175718-D69CA66D-E637-4916-BB70-BFF5D30A71CB Q57183034-6BA428DF-EE4A-4956-8E67-B2C07EFF7B6C Q58553983-EBD83930-0CD9-4545-9C4C-65DD3D3D4FBE Q58603525-4DBBEDEE-D30F-47B9-8BFA-A9E4F49F65CC Q58695149-66D98903-591E-42D1-AC2F-9A4CAA001D90 Q58799080-51A8D304-A11D-4416-9874-FE737B4502EC Q59136184-69F6EC03-8B60-40D7-830E-109764209768

P2860

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

http://www.wikidata.org/entity/Q34363511

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

@ast

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

@en

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

@nl

type

label

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

@ast

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

@en

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

@nl

prefLabel

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

@ast

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

@en

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

@nl

P1433

Q34363511-6B0CC382-6214-43BE-8A2B-A1EE6AB39DF6

P1476

Q34363511-73522C9B-15C5-4213-8E6E-7241FBDF9FA8

P2093

Q34363511-0F53D085-7ABC-45CF-971B-36895BDC0989

Q34363511-2CDC7215-2579-40D5-9569-973C854293B3

Q34363511-2FB81418-E286-41B7-B33B-15CBEFDFD155

Q34363511-7DBF6CDA-A89D-4C3B-8F99-78E7C877C545

Q34363511-AE9B51A9-CE44-48BF-B1BD-953B06A1DB7C

Q34363511-C32FF2DF-585C-4AB8-91C3-D374B6C5769E

Q34363511-D77CA802-DCF8-4582-886F-F692FA2989C9

Q34363511-F63FBCBA-DFC2-4C72-B404-8F1C59207588

P2860

Q34363511-00AD9ADF-DE23-4C44-AFFC-1DA564C1B8C5

Q34363511-08F1CCF1-94E4-44B8-9227-09C148F0F747

Q34363511-11D1F0DF-E615-4A99-A158-7D07CE75C1DC

Q34363511-20F60DBC-5915-42D0-93D2-B353C40671EF

Q34363511-229C692B-4B68-4368-9549-6879184108B6

Q34363511-315FE2C1-ED72-4CB8-8529-A7FE7BF04818

Q34363511-3391CA1D-33C6-48B7-8FD2-B031A991D4DC

Q34363511-33A95336-F348-4BEC-A000-02D30587E01B

Q34363511-3DA555EF-5D03-4B3F-A719-0277F0A37DCB

Q34363511-4509513F-B2EE-4BD2-B219-D950A99545FA

P2888

Q34363511-7FCF7097-7BE1-45D6-A200-96E585153ADA

P304

Q34363511-9569D930-9F20-41A5-8E78-62ABFAFB26B5

P31

Q34363511-7432B221-E709-453A-9FD3-8159D49A0980

P356

Q34363511-23B8E945-9B05-4301-B778-1B6AA77E62D4

P433

Q34363511-47BC590C-26B9-4FC5-B1CA-C0679B50DC2C

P478

Q34363511-2EDA2EA3-3FBB-42D8-8162-3D4EC5181865

P50

Q34363511-0A7E4FEA-2E98-44B5-A2B1-69904F274D3A

Q34363511-23B3FF80-33B3-4542-8001-63D39AF8FE5D

Q34363511-81C83E84-B6A4-41A3-9D2B-5B46970B4721

Q34363511-86E1A136-D1F1-4393-A044-130E1A3D8987

Q34363511-8BBBDB2F-E444-4FCA-9D4E-870D0D8AA35B

Q34363511-B8057F4F-B6D7-47C2-98E5-AB29389EB67E

P577

Q34363511-54E69C8F-42E8-4337-A662-1844F06259D1

P5875

Q34363511-0404B297-224B-4483-9817-8DEC53F497ED

P6179

Q34363511-DCC1379E-8A32-4967-B3D7-A8E3914E6E7D

P698

Q34363511-22206DAC-E26A-4D42-B7E5-55FD7B3A1055

P921

Q34363511-01D03A90-2133-4E6B-9807-AD78BBB12495

Q34363511-A86BC997-4B0A-41C3-BA44-6A53868F064E

P932

Q34363511-11B08602-1A44-428B-BDE3-029DF2C401CB

P356

S00401-014-1345-4

P1433

Acta Neuropathologica

P1476

Inflammatory dysregulation of blood monocytes in Parkinson's disease patients.

@en

P2093

Bastian Hengerer

http://www.w3.org/2001/XMLSchema#string

Corinna Bliederhaeuser

http://www.w3.org/2001/XMLSchema#string

Jochen H Weishaupt

http://www.w3.org/2001/XMLSchema#string

Karin M Danzer

http://www.w3.org/2001/XMLSchema#string

Kathrin Fundel-Clemens

http://www.w3.org/2001/XMLSchema#string

Valerie Roth

http://www.w3.org/2001/XMLSchema#string

Veselin Grozdanov

http://www.w3.org/2001/XMLSchema#string

Wolfgang P Ruf

http://www.w3.org/2001/XMLSchema#string

P2860

Blood monocytes: development, heterogeneity, and relationship with dendritic cells

DJ-1 inhibits TRAIL-induced apoptosis by blocking pro-caspase-8 recruitment to FADD

Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses

Parkinsonism: onset, progression and mortality

Identification of a unique TGF-β-dependent molecular and functional signature in microglia

Blood monocytes consist of two principal subsets with distinct migratory properties

Genesis: cluster analysis of microarray data

Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

Nomenclature of monocytes and dendritic cells in blood.

Pharmacokinetics, pharmacodynamics, safety and tolerability of APG101, a CD95-Fc fusion protein, in healthy volunteers and two glioma patients.

P2888

s00401-014-1345-4

P304

651-663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-014-1345-4

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

David A. Brenner

Ana Martin-Villalba

Albert C Ludolph

P577

2014-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266622777

http://www.w3.org/2001/XMLSchema#string

P6179

1044116109

http://www.w3.org/2001/XMLSchema#string

P698

25284487

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4201759

http://www.w3.org/2001/XMLSchema#string